Monkeypox

8. Vaccination

As recommended by the WHO at the end of 2022, the term "mpox" is now being used as a synonym for "monkeypox".

Vaccination against mpox began in Geneva on Tuesday 15th November 2022 with the Jynneos vaccine, in collaboration with the General Directorate of Health, the University Hospital of Geneva and the associative sector. Two subcutaneous doses are proposed at 28-day intervals, unless there are special situations (first vaccination carried out elsewhere, previous vaccination against human smallpox for example).

Vaccination against mpox is one measure among others: it protects partially, but not 100%, and it is necessary to continue to be cautious. If you have any symptoms:

  • get tested,
  • cover the sores,
  • avoid all intimate contact.
     
Purpose of mpox vaccination
  • To reduce the risk of infection
  • To reduce the severity of symptoms in the event of illness
  • To protect vulnerable people (children, pregnant women and people who are at risk of serious complications if they are infected)
 
Usual vaccination scheme

Two doses of MVA-BN vaccine with a minimum of 28 days between the two doses.
 

Persons eligible for vaccination

According to the FOPH criteria, vaccination against mpox is recommended for people who have the highest probability of being infected with the mpox virus. These are:

  • Multipartner men (men who have sex with men - MSM) and multipartner trans* people,
  • People who may be at risk of exposure to the mpox virus for professional reasons and despite protective equipment (medical personnel, specialized laboratory personnel, etc.),
  • people who have had risky contacts with people who are ill according to the FOPH criteria, but who have not yet developed the disease.

If you meet these criteria and would like to be vaccinated against mpox, we invite you to contact Checkpoint, Groupe Santé Genève or the dermatology department of the HUG. These facilities handle part of the registration process, and anyone who is interested and meets the above criteria may write directly either one of these addresses to request registration:


Vaccination process

Registered persons receive a text message with the appointment time and date for the first dose, as well as a number to call to change the appointment date if necessary. The text message does not mention the term "mpox" or "monkeypox."

Individuals will be greeted by trained staff to ensure a warm, non-judgmental welcome.

Patients must present themselves at the reception desk with a document confirming their identity (identity card, passport, driver's license, etc.). A residence permit and legal address are not required and will not be requested.

No screening will be performed at the vaccination site except for the usual contraindications to any vaccination procedure.

Vaccination cannot be performed anonymously. As with all medical and vaccination data, the information concerning this vaccination is confidential. The names of the persons registered are shared only with the persons in charge of vaccination, and they are subject to professional confidentiality, medical confidentiality and duty confidentiality. No information is passed on to a third party. Data security is ensured by a computer system containing all the necessary guarantees.

 

You will find further information related to mpox vaccination here: 

Factsheet - mpox (formerly Monkeypox)

Last updated
27 January 2023

Is this page useful ?